© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
October 05, 2015
During the early years of the "meaningful use" program, surveys found decreases in both optimism and concerns about electronic health records.
September 30, 2015
Patient-reported outcomes, through the use of new technological advances, can be successfully integrated into routine orthopedic practice and shared across distinct institutions.
This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.
This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.
September 14, 2015
The characteristics of patients who visit practices that are ready versus unready for the patient-centered medical home differ in important ways.
September 10, 2015
Four years following engagement by an urban care organization in global payment contracts, a majority of internal medicine physicians there were supportive of this action.
As delivery system reforms increasingly rely on a strong primary care workforce, policies are needed to grow and strengthen this workforce.
August 18, 2015
An analysis of the opportunity cost associated with ambulatory medical care in the United States demonstrates substantial time costs for individuals and society.
Analysis of publicly reported organizational characteristics, shared savings distribution plans, and early financial success of accountable care organizations in the Medicare Shared Savings Program.
Compared with traditional Medicare, relative resource use for those with diabetes or cardiovascular disease is lower in Medicare Advantage, while quality of care is higher.
Assessment of prevalence and specific costs associated with discrete multimorbid mental health disease clusters in adults with diabetes.
Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.